Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
Can we halve antibiotic time for dangerous blood infections?
Disease control OngoingThis study is comparing whether 7 days of antibiotics works as well as the standard 14-day course for treating a specific and serious bloodstream infection caused by Pseudomonas aeruginosa. It involves 306 adult patients and aims to see if the shorter treatment is just as effecti…
Phase: PHASE4 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Race to find safer stroke treatment: new drug challenge for blocked neck artery
Disease control OngoingThis study aims to find the safest and most effective blood-thinning medication for patients experiencing a severe stroke caused by a blockage in both the neck and brain arteries. It will compare two drugs, Tirofiban and intravenous Aspirin, in 240 patients who receive emergency …
Phase: PHASE4 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New stitch vs. old stitch: which better prevents hernias after cancer surgery?
Prevention OngoingThis study compares two types of surgical stitches used to close large abdominal incisions after cancer surgery. It aims to see if a newer, barbed stitch (Stratafix) is better than a standard stitch at preventing a painful complication called an incisional hernia. The trial invol…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC
-
Scientists probe Gut's role in dangerous transplant complication
Knowledge-focused OngoingThis study aims to understand if changes in a patient's gut bacteria and the chemicals they produce are linked to a serious complication called graft-versus-host disease (GVHD) after a stem cell transplant. Researchers will collect stool and blood samples from 88 transplant patie…
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC